Literature DB >> 26884392

Optimization of Geriatric Pharmacotherapy: Role of Multifaceted Cooperation in the Hospital Setting.

Mirko Petrovic1, Annemie Somers2, Graziano Onder3.   

Abstract

Because older patients are more vulnerable to adverse drug-related events, there is a need to ensure appropriate pharmacotherapy in these patients. This narrative review describes approaches to improve pharmacotherapy in older people in the hospital setting. Screening to identify older patients at risk of drug-related problems and adverse drug reactions (ADRs) is the first critical step within a multistep approach to geriatric pharmacotherapy. Two methods that have been developed are the GerontoNet ADR risk score and the Brighton Adverse Drug Reactions Risk (BADRI) model, which take into account a number of factors, the most important of which is the number of medicines. In order to reduce potentially inappropriate prescribing in older patients, different types of interventions exist, such as pharmacist-led medication reviews, educational interventions, computerized decision support systems, and comprehensive geriatric assessment. The effects of these interventions have been studied, sometimes in a multifaceted approach, by combining different techniques. None of the existing interventions shows a clear beneficial effect on patients' health outcomes if applied in isolation; however, when these interventions are combined within the context of a multidisciplinary team, positive effects on patients' health outcomes can be expected. Appropriate geriatric pharmacotherapy, global assessment of patients' clinical and functional parameters, and integration of skills from different healthcare professionals are needed to address medical complexity of older adults.

Entities:  

Mesh:

Year:  2016        PMID: 26884392     DOI: 10.1007/s40266-016-0352-7

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  71 in total

Review 1.  Adverse drug reactions in older people: detection and prevention.

Authors:  Mirko Petrovic; Tischa van der Cammen; Graziano Onder
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

Review 2.  Do educational interventions improve prescribing by medical students and junior doctors? A systematic review.

Authors:  Sarah Ross; Yoon K Loke
Journal:  Br J Clin Pharmacol       Date:  2009-06       Impact factor: 4.335

Review 3.  Strategies to reduce the risk of iatrogenic illness in complex older adults.

Authors:  Graziano Onder; Tischa J M van der Cammen; Mirko Petrovic; Annemie Somers; Chakravarthi Rajkumar
Journal:  Age Ageing       Date:  2013-03-28       Impact factor: 10.668

Review 4.  Optimising drug treatment for elderly people: the prescribing cascade.

Authors:  P A Rochon; J H Gurwitz
Journal:  BMJ       Date:  1997-10-25

5.  Polypharmacy and prescribing quality in older people.

Authors:  Michael A Steinman; C Seth Landefeld; Gary E Rosenthal; Daniel Berthenthal; Saunak Sen; Peter J Kaboli
Journal:  J Am Geriatr Soc       Date:  2006-10       Impact factor: 5.562

6.  Adverse drug reaction risk factors in older outpatients.

Authors:  Emily R Hajjar; Joseph T Hanlon; Margaret B Artz; Catherine I Lindblad; Carl F Pieper; Richard J Sloane; Christine M Ruby; Kenneth E Schmader
Journal:  Am J Geriatr Pharmacother       Date:  2003-12

7.  An innovative approach to integrated medicines management.

Authors:  Claire Scullin; Michael G Scott; Anita Hogg; James C McElnay
Journal:  J Eval Clin Pract       Date:  2007-10       Impact factor: 2.431

8.  The clinical pharmacology of ageing.

Authors:  C G Swift
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

9.  Using prescribing indicators to measure the quality of prescribing to elderly medical in-patients.

Authors:  Gwenno M Batty; Robert L Grant; Reena Aggarwal; Derek Lowe; Jonathon M Potter; Michael G Pearson; Stephen H D Jackson
Journal:  Age Ageing       Date:  2003-05       Impact factor: 10.668

10.  The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study.

Authors:  Sture Rognstad; Mette Brekke; Arne Fetveit; Olav Spigset; Torgeir Bruun Wyller; Jørund Straand
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

View more
  17 in total

1.  Aging of the Population, Clinical Pharmacy Services, and Interdisciplinary Cooperation in the Optimization of Pharmacotherapy in Older Patients.

Authors:  Daniela Fialová; Franciska Desplenter
Journal:  Drugs Aging       Date:  2016-03       Impact factor: 3.923

2.  Hospital Pharmacy in Belgium: From Moving Boxes to Providing Optimal Therapy.

Authors:  Thomas De Rijdt; Franciska Desplenter
Journal:  Can J Hosp Pharm       Date:  2016-04-29

3.  Mapping of drug-related problems among older adults conciliating medical and pharmaceutical approaches.

Authors:  Marie-Laure Laroche; Thi Hong Van Ngo; Caroline Sirois; Amélie Daveluy; Michel Guillaumin; Marie-Blanche Valnet-Rabier; Muriel Grau; Barbara Roux; Louis Merle
Journal:  Eur Geriatr Med       Date:  2021-03-20       Impact factor: 1.710

Review 4.  Clinical Pharmacy Services in Older Inpatients: An Evidence-Based Review.

Authors:  Lorenz Van der Linden; Julie Hias; Karolien Walgraeve; Johan Flamaing; Jos Tournoy; Isabel Spriet
Journal:  Drugs Aging       Date:  2020-03       Impact factor: 3.923

5.  Contribution of Patient Interviews as Part of a Comprehensive Approach to the Identification of Drug-Related Problems on Geriatric Wards.

Authors:  Dominik Stämpfli; Fabienne Boeni; Andy Gerber; Victor A D Bättig; Kurt E Hersberger; Markus L Lampert
Journal:  Drugs Aging       Date:  2018-07       Impact factor: 3.923

6.  Combined Use of the Rationalization of Home Medication by an Adjusted STOPP in Older Patients (RASP) List and a Pharmacist-Led Medication Review in Very Old Inpatients: Impact on Quality of Prescribing and Clinical Outcome.

Authors:  Lorenz Van der Linden; Liesbeth Decoutere; Karolien Walgraeve; Koen Milisen; Johan Flamaing; Isabel Spriet; Jos Tournoy
Journal:  Drugs Aging       Date:  2017-02       Impact factor: 3.923

7.  The role of pharmacists in geriatric teams: the time is now.

Authors:  E Delgado-Silveira; T Bermejo-Vicedo
Journal:  Eur Geriatr Med       Date:  2021-12       Impact factor: 1.710

8.  Consensus validation of a screening tool for cardiovascular pharmacotherapy in geriatric patients: the RASP_CARDIO list (Rationalization of Home Medication by an Adjusted STOPP list in Older Patients).

Authors:  Hannah De Schutter; Julie Hias; Laura Hellemans; Karolien Walgraeve; Jos Tournoy; Peter Verhamme; Peter Sinnaeve; Rik Willems; Walter Droogné; Christophe Vandenbriele; Lucas Van Aelst; Thomas Vanassche; Lorenz Van der Linden
Journal:  Eur Geriatr Med       Date:  2022-10-14       Impact factor: 3.269

9.  Clinical impact of an interdisciplinary patient safety program for managing drug-related problems in a long-term care hospital.

Authors:  Oreto Ruiz-Millo; Mónica Climente-Martí; Ana María Galbis-Bernácer; José Ramón Navarro-Sanz
Journal:  Int J Clin Pharm       Date:  2017-10-19

10.  Impact of pharmaceutical care on the quality of life of patients with heart failure due to chronic Chagas disease: Randomized clinical trial.

Authors:  Mayara da Costa Chambela; Mauro Felippe Felix Mediano; Fernanda Martins Carneiro; Roberto Rodrigues Ferreira; Mariana Caldas Waghabi; Verônica Gonçalves Mendes; Luciano de Souza Oliveira; Marcelo Teixeira de Holanda; Andréa Silvestre de Sousa; Andréa Rodrigues da Costa; Sérgio Salles Xavier; Gilberto Marcelo Sperandio da Silva; Roberto Magalhães Saraiva
Journal:  Br J Clin Pharmacol       Date:  2019-11-27       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.